| DAY - 1, 23 August 2014 | |||
|---|---|---|---|
| CRYSTAL BALLROOM | |||
| 8.00 - 10.00 AM | REGISTRATION | ||
| 10.00 - 10.15 AM | INTRODUCTION AND WELCOME | ||
| 10.15 - 11.30 AM | Session 1- Pathophysiology of Type 2 Diabetes | Speaker | Chairperson |
| 10.15 - 10.30 AM | Insulin Resistance - Muscle, Liver or Adipose Tissue? | Adi Mehta | B. M. Makkar, Vinod Mittal |
| 10.30 - 10.45 AM | CNS and Type 2 Diabetes - Is there a real link? | Robert Zimmerman | |
| 10.45 - 11.00 AM | Deranged Islet Pathophysiology | Adi Mehta | |
| 11.00 - 11.15 AM | Renal Contribution to Hyperglycemia | Kevin Pantalone | |
| 11.15 - 11.30 AM | Discussion | ||
| 11.30 - 12.00 PM | TEA BREAK | ||
| 12.00 - 1.15 PM | Session 2 – Hyperglycemia Management | Speaker | Chairperson |
| 12.00 - 12.20 PM | Hyperglycemia Management Guidelines – Practical Implications in Indian Setting? | V Mohan | Shashank Joshi, Banshi Saboo |
| 12.20 - 12.40 PM | Metformin – Why preferred 1st line drug? | Robert Zimmerman | |
| 12.40 - 1.00 PM | Sulfonylureas – do they really increase risk | Kevin Pantalone | |
| 1.00 - 1.15 PM | Discussion | ||
| 1.15 - 2.15 PM | LUNCH BREAK | ||
| 1.45 - 2.20 PM | MEET THE PROFESSOR | ||
| Initiating Insulin in Type 2 Diabetes – is it always basal or we have other options. | V Mohan, Kevin Pantalone, Banshi Saboo |
||
| 2.30 - 4.10 PM | Session 3 – Emerging Therapies | Speaker | Chairperson |
| 2.30 - 2.50 PM | GLP1 Analogues – what’s new? | Ambrish Mithal | A. K. Jhingan, Kevin Pantalone |
| 2.50 - 3.10 PM | GLP1 Analogues and Insulin Combination Therapy | Kevin Pantalone | |
| 3.10 - 3.30 PM | SGLT 2 Inhibitors – Is Glycosuria Good? | Robert Zimmerman | |
| 3.30 - 3.50 PM | Glitazars – Do they offer promise for the future? | Shashank Joshi | |
| 3.50 - 4.10 PM | Discussion | ||
| 4.10 - 4.30 PM | TEA BREAK | ||
| 4.30 - 5.45 PM | Session 4 – Obesity Updated | Speaker | Chairperson |
| 4.30 - 4.50 PM | Indian Obesity – The Asian Indian Phenotype | Shashank Joshi | Ambrish Mithal, Rajeev Chawla |
| 4.50 - 5.10 PM | Gut Microbiota - Does Poop Hold the Answer? | Adi Mehta | |
| 5.10 - 5.30 PM | New Pharmacologics for Obesity- Much Ado About So Little? |
Kevin Pantalone | |
| 5.30 - 5.45 PM | Discussion | ||
| 5.45 - 7.00 PM | DEBATES | Speaker | Chairperson |
| 5.45 - 6.30 PM | Debate 1 - Managing Triglcerides is important in Indian diabetics – Debate |
Yes - Shashank Joshi No - Adi Mehta |
Kevin Pantalone BanshiSaboo Rakesh Gupta |
| 6.30 - 7.15 PM | Debate 2 - To Sulfonylureas or Not to Sulfonylureas, That is The Question? | No - Robert Zimmerman, Yes- B. M. Makkar | |
| 7.45 PM Onward | BANQUET | ||
| REGENCY III & IV | |||
| 11.30 - 12.00 PM | TEA BREAK | ||
| 1.15 - 2.15 PM | LUNCH BREAK | ||
| 1.45 - 2.20 PM | MEET THE PROFESSOR | ||
| Vit D and Type 2 Diabetes – Do we give it to all? | AmbrishMithal, Adi Mehta, Shashank Joshi | ||
| 4.10 - 4.30 PM | TEA BREAK | ||
| REGENCY V | |||
| 11.30 - 12.00 PM | TEA BREAK | ||
| 1.15 - 2.15 PM | LUNCH BREAK | ||
| 1.45 - 2.20 PM | MEET THE PROFESSOR | ||
| Achieving Good Glycemic Control – Role of SMBG, A1C and CGMS | Robert Zimmerman, B. M. Makkar | ||
| 4.10 - 4.30 PM | TEA BREAK | ||
| DAY - 2, 24 August 2014 | |||
| CRYSTAL BALLROOM | |||
| 9.00 - 10.15 AM | Session 1 | Speaker | Chairperson |
| 9.00 - 9.20 AM | New Hypertension Guidelines - Are We Regressing? | Adi Mehta | Arvind Gupta, V. K. Goyal |
| 9.20 - 9.40 AM | DPP4 Inhibitors –safety status/issues after SAVOR- TIMI & EXAMINE. | Kevin Pantalone | |
| 9.40 - 10.00 AM | New vs. Old Lipid Management Guidelines - Are They Really A Step Forward? |
Adi Mehta | |
| 10.00 - 10.15 AM | Discussion | ||
| 10.15 - 10.45 AM | Update Lecture 1- Transitioning to Insulin Programs | Adi Mehta | Shashank Joshi, Atul Luthra |
| 10.45 - 11.15 AM | Update Lecture 2- Insulins of Future | Robert Zimmerman | |
| 11.15 - 11.45 AM | TEA BREAK | ||
| 11.45 - 01.00 PM | Session 2 | Speaker | Chairperson |
| 11.45 - 12.05 PM | Comeback of Glitazones – Where do they stand in today’s clinical practice | Shashank Joshi | Robert Zimmerman, R. K. Lalwani |
| 12.05 - 12.25 PM | Cholesterol Management2015 – Role of Non-Statins | Adi Mehta | |
| 12.25 - 12.45 PM | Inpatient Hyperglycemia Management | Ambrish Mithal | |
| 12.45 - 1.00 PM | Discussion | ||
| 1.00 - 2.00 PM | LUNCH BREAK | ||
| 1.30 - 2.20 PM | MEET THE PROFESSOR | ||
| How Early Can One Identify Progression of Type 2 Diabetes |
V. Mohan, Adi Mehta | ||
| 2.30 - 4.00 PM | Session 3 | Speaker | Chairperson |
| 2.30 - 2.50 PM | Has time come to take genomics to the diabetes centre? | V. Mohan | B. M. Makkar, Rajeev Chawla |
| 2.50 - 3.10 PM | Hypoandrogenic hypogonadism in Type 2 Diabetes | Kevin Pantalone | |
| 3.10 - 3.30 PM | Practical Hypertension Therapy Choices | Robert Zimmerman | |
| 3.30 - 3.50 PM | Is Diabetes Preventable in 21st Century? | Adi Mehta | |
| 3.50 - 4.10 PM | Discussion | ||
| 4.10 - 4.30 PM | Wrap Up and Valedictory | ||
| TEA BREAK and CLOSE | |||
| REGENCY III & IV | |||
| 11.15 - 11.45 AM | TEA BREAK | ||
| 1.00 - 2.00 PM | LUNCH BREAK | ||
| 1.30 - 2.20 PM | MEET THE PROFESSOR | ||
| What should be the 2nd line therapy, after metformin, for the majority of DM-2 patients with inadequate glycemic control |
Ambrish Mithal, Kevin Pantalone | ||
| REGENCY V | |||
| 11.15 - 11.45 AM | TEA BREAK | ||
| 1.00 - 2.00 PM | LUNCH BREAK | ||
| 1.30 - 2.20 PM | Q & A (Leftover questions+Misc) | Robert Zimmerman, Shashank Joshi | |
Scientific Program ::
Navigation
Downloads
Enquiry
Contact
Suite No. 510/511, DLF City Court
MG Road, Gurgaon 122 004 , Haryana, India
Pratibha Verma
Mob: +91 965 06 07 824
Tel: +91-124 46 17 718
Fax: +91-124 46 17 777